Search

everythinglearnresearchcommunity

for

Search:↓

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

The supplement improved hair health and reduced shedding in people with telogen effluvium.

PP-PTKL may help treat hair greying, but more testing is needed.

Choose anti-epileptic drugs carefully for women of childbearing age to avoid risks during pregnancy.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

The higher dose supplement was more effective in treating female hair loss.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Systemic cyproterone acetate and 5% topical minoxidil are effective and safe for treating female pattern hair loss.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Letrozole may help prevent seizures by reducing certain hormone levels.

Taking 5 mg/day finasteride can cause side effects in women with hair loss, but these are usually mild and fade over time, making the treatment beneficial in the long run.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.